|1.||Brewer, K L: 6 articles (01/2004 - 01/2000)|
|2.||Brewer, Kori L: 5 articles (07/2009 - 02/2004)|
|3.||Abraham, K E: 5 articles (01/2004 - 01/2000)|
|4.||Tu, Jian: 3 articles (01/2015 - 06/2003)|
|5.||Lee, Jeung Woon: 3 articles (01/2012 - 07/2008)|
|6.||Eaton, Mary J: 3 articles (01/2009 - 01/2007)|
|7.||Yezierski, Robert P: 3 articles (11/2008 - 04/2003)|
|8.||McGinty, J F: 3 articles (02/2001 - 01/2000)|
|9.||Sagen, Jacqueline: 2 articles (01/2012 - 07/2008)|
|10.||Furmanski, Orion: 2 articles (01/2012 - 07/2008)|
07/01/1994 - "Quisqualic acid-induced seizures during development: a behavioral and EEG study."
10/01/1987 - "The present studies demonstrated that the microinjection of quisqualic acid (QA) into unilateral amygdala in chronically implanted cats resulted in various types of limbic seizures in accordance with injected doses. "
08/17/1998 - "A sublethal i.c.v. dose of quisqualate caused episodes of prolonged akinesia and convulsions, and major damage to pyramidal neurons of the hippocampal CA1 and CA3 sector, but not to granule cell neurons of the dentate gyrus. "
11/30/1993 - "I.c.v. infusion of the non-selective metabotropic receptor agonists ibotenate (6 nmol/min) or quisqualate (30 nmol/min) induced clonic convulsions. "
01/01/1986 - "GDEE given by intraperitoneal blocked quisqualate-induced seizures dose-dependently. "
01/01/2006 - "The pain model used unilateral intraspinal injection of quisqualic acid (QUIS) into the dorsal horn between vertebral levels T13 and L1. "
02/01/2001 - "Intraspinal injection of quisqualic acid (QUIS) produces an excitotoxic injury that leads to the onset of behavioral syndromes, believed to be related to the clinical condition of chronic pain. "
01/01/2004 - "Using the quisqualic acid model of spinal cord injury, we examined the extent of gray matter damage and onset of injury-induced pain behaviors at various time points following injury in wild-type vs. IL-10((-/-)) mice. "
01/01/2001 - "AIDA, but not NBQX, significantly reduced the frequency of, and delayed the onset of, quisqualic acid-induced spontaneous pain-related behavior. "
02/01/2015 - "We assessed the effects of intraplantar quisqualate, a non-selective glutamate receptor agonist, on heat and mechanical pain behaviours in mice. "
|3.||Spinal Cord Injuries (Spinal Cord Injury)
07/01/2009 - "Spinal cord injury was induced by unilateral microinjections of quisqualic acid at spinal levels T12-L2. "
11/01/2008 - "Injecting quisqualate (QUIS) into the rat spinal cord models spinal cord injury (SCI) and causes at-level scratching and self-injury. "
07/06/1998 - "Previous studies have shown that intraspinal injection of quisqualic acid (QUIS) produces excitotoxic injury with pathological characteristics similar to those associated with ischemic and traumatic spinal cord injury (SCI). "
03/01/2001 - "Intraspinal injection of quisqualic acid (QUIS) produces excitotoxic injury with pathophysiological characteristics similar to those associated with ischemic and traumatic spinal cord injury (SCI). "
01/01/2000 - "Intraspinal injection of quisqualic acid produces an excitotoxic injury with pathological characteristics similar to those associated with ischemic and traumatic spinal cord injury. "
|4.||Alzheimer Disease (Alzheimer's Disease)
12/01/1990 - "This strongly suggests that quisqualate lesions of the NBM are not sufficient to produce severe and lasting mnemonic disorders resembling those seen in Alzheimer's disease (AD). "
12/01/1990 - "Quisqualate (AMPA) receptor binding was markedly reduced in the molecular layer of the cerebellum from patients with Alzheimer's disease (167 +/- 13 pmoles/gm) compared with control patients (280 +/- 13 pmoles/gm). "
04/01/1990 - "Binding was decreased significantly for all ligands except quisqualate in stratum pyramidale of CA1 of the Alzheimer's disease brains. "
01/01/1990 - "The number of binding sites was then determined in parallel with choline acetyltransferase activity in the temporal cortex of patients with Alzheimer's disease, demented and non-demented patients with Parkinson's disease, and in the cerebral cortex of rats with quisqualic acid lesions of the nucleus basalis magnocellularis. "
04/01/1990 - "Quantitative receptor autoradiography was used to measure muscarinic cholinergic, benzodiazepine, kainate, phencyclidine (PCP), N-methyl-D-aspartate (NMDA) (measured in Tris acetate), quisqualate-sensitive, non-quisqualate-sensitive and total glutamate (measured in Tris chloride buffer) binding sites in adjacent sections of the hippocampal region of 10 Alzheimer's disease, nine control, and six demented, non-Alzheimer's disease postmortem human brains. "
|5.||Olivopontocerebellar Atrophies (Olivopontocerebellar Atrophy)
|4.||2,3- dioxo- 6- nitro- 7- sulfamoylbenzo(f)quinoxaline (NBQX)
|6.||Kainic Acid (Kainate)
|7.||Aspartic Acid (Aspartate)
|8.||Opioid Peptides (Opioid Peptide)
|9.||Glutamic Acid (Glutamate)
|10.||alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)